Edition:
United States

Chiasma Inc (CXS.F)

CXS.F on Frankfurt Stock Exchange

2.28EUR
26 Aug 2016
Change (% chg)

€-0.06 (-2.48%)
Prev Close
€2.34
Open
€2.28
Day's High
€2.35
Day's Low
€2.28
Volume
--
Avg. Vol
2,679
52-wk High
€25.34
52-wk Low
€2.20

Latest Key Developments (Source: Significant Developments)

Chiasma adopts a retention plan to provide cash retention payments to all remaining employees
Tuesday, 16 Aug 2016 09:59am EDT 

Chiasma Inc : Adopted a retention plan, effective immediately to provide cash retention payments to all remaining employees of co- sec filing . Retention payments are expected to be made in January 2017 Source: (http://bit.ly/2b1crqL) Further company coverage: [CHMA.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Chiasma announces workforce reduction
Tuesday, 16 Aug 2016 09:00am EDT 

Chiasma Inc : Chiasma announces workforce reduction . Continues to enroll patients in its mpowered phase 3 trial . Further reducing its workforce by approximately 44% . Will incur aggregate charges related to headcount reduction of about $0.8 million to $1.0 million for one-time severance and related costs in Q3 . Company expects to realize more than $7.0 million in annualized payroll and related expense savings as a result of restructuring actions . Chiasma Inc says expects to realize more than $7.0 million in annualized payroll and related expense savings as a result of these combined actions .Charges related to headcount reduction expected to result in cash expenditures that will be substantially complete by end of Q1 of 2017.  Full Article

Chiasma records restructuring charge of about $6.5 mln in Q2
Wednesday, 10 Aug 2016 04:02pm EDT 

Chiasma Inc : Chiasma provides corporate update and reports second quarter 2016 results . Recorded a restructuring charge of approximately $6.5 million for quarter ended June 30, 2016 . Chiasma Inc qtrly basic loss per share $1.10 .Approximately $1.8 million of charge was attributable to restructuring plan that was announced in June 2016.  Full Article

Chiasma Inc terminates employment of CCO Anand Varadan
Tuesday, 14 Jun 2016 09:18am EDT 

Chiasma Inc :Terminated employment of Anand Varadan, company's chief commercial officer, effective as of June 17, 2016 - sec filing.  Full Article

Chiasma Q1 loss per share $0.71
Wednesday, 11 May 2016 04:01pm EDT 

Chiasma Inc : Currently revisiting all areas of investment and resources in light of recent receipt of CRL . Revisiting resources to potentially enable an overall reduction of its 2016 expenses and an extension of its cash runway beyond mid-2017 . Qtrly loss per share $0.71 .Chiasma reports first quarter 2016 results.  Full Article

Chiasma announces FDA acceptance for filing of new drug application for Octreotide Capsules in Acromegaly
Monday, 17 Aug 2015 07:00am EDT 

Chiasma Inc:Says that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for the marketing and sale of octreotide capsules, an oral drug proposed for the maintenance therapy of adult patients with acromegaly.  Full Article

Chiasma Inc. announces closing of initial public offering and full exercise of underwriters' option to purchase additional shares
Tuesday, 21 Jul 2015 04:07pm EDT 

Chiasma Inc:Says closing of its initial public offering of 7,319,750 shares of common stock at a price of $16.00 per share, before underwriting discounts, which includes the exercise in full by the underwriters of their option to purchase up to 954,750 additional shares of common stock.All of the common stock was offered by Chiasma. Chiasma's stock is listed on The NASDAQ Global Select Market under the ticker symbol CHMA.Barclays Capital Inc. and Cowen and Company, LLC acted as joint book-running managers for the offering.William Blair & Company, L.L.C. and Oppenheimer & Co. Inc. acted as co-managers.  Full Article

Chiasma Inc prices initial public offering of common stock
Wednesday, 15 Jul 2015 07:49pm EDT 

Chiasma Inc:Announces the pricing of its initial public offering of 6,365,000 shares of common stock at a price of $16.00 per share, before underwriting discounts.Says Barclays Capital Inc. and Cowen and Company, LLC acted as joint book-running managers for the offerin.Says William Blair & Company, L.L.C. and Oppenheimer & Co. Inc. acted as co-managers.  Full Article

BRIEF-Chiasma adopts a retention plan to provide cash retention payments to all remaining employees

* Adopted a retention plan, effective immediately to provide cash retention payments to all remaining employees of co- sec filing